Sandu Pharmaceuticals Limited (BOM:524703)
33.01
+1.22 (3.84%)
At close: Jan 22, 2026
Sandu Pharmaceuticals Revenue
Sandu Pharmaceuticals had revenue of 176.21M INR in the quarter ending September 30, 2025, a decrease of -0.47%. This brings the company's revenue in the last twelve months to 667.62M, down -1.48% year-over-year. In the fiscal year ending March 31, 2025, Sandu Pharmaceuticals had annual revenue of 671.92M, down -0.13%.
Revenue (ttm)
667.62M
Revenue Growth
-1.48%
P/S Ratio
0.48
Revenue / Employee
2.20M
Employees
303
Market Cap
319.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 671.92M | -883.00K | -0.13% |
| Mar 31, 2024 | 672.81M | 19.32M | 2.96% |
| Mar 31, 2023 | 653.49M | -1.52M | -0.23% |
| Mar 31, 2022 | 655.01M | 67.45M | 11.48% |
| Mar 31, 2021 | 587.55M | 103.10M | 21.28% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| ANG Lifesciences India | 922.09M |
| Deccan Health Care | 847.12M |
| Walpar Nutritions | 757.46M |
| JFL Life Sciences | 744.78M |
| Gujarat Terce Laboratories | 501.95M |
| Panjon | 463.51M |